A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus St
A phase 2 trial of ABBV-706, Atezolizumab, Etoposide in small-cell lung cancer, run by AbbVie, now recruiting.
Overview
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer is a phase 2 interventional study registered as NCT07155174 by AbbVie, with 180 participants planned, started 2025-11-25 and due to reach its primary completion in 2029-04. Interventions recorded: ABBV-706, Atezolizumab, Etoposide, Carboplatin, Carboplatin. Conditions listed: Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialBL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Shares Lurbinectedin, Etoposide, Atezolizumab, Carboplatin.
- TrialA Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Shares Lurbinectedin, Etoposide, Atezolizumab, Carboplatin.
- TrialDAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialA Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialPembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialA Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- TrialStudy of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.